Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease

Keyphrases

• Cardiovascular Disease 100%
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) 100%
• Cardiovascular Risk 25%
• Cell Function 12%
• Major Contributor 12%
• Receptor Signaling 12%
• Glycoprotein 12%
• Diverse Populations 12%
• Vascular Inflammation 12%
• Chronic Inflammation 12%
• Disease Pathogenesis 12%
• Pathogenic Factors 12%
• Myeloid Cells 12%
• Cardiovascular Events 12%
• Ongoing Clinical Trials 12%
• Therapeutic Target 12%
• Prognostic Indicator 12%
• Monocyte Activation 12%
• Monocyte Function 12%
• Clinical Genetics 12%
• Atherosclerotic Disease 12%
• Cardiovascular Risk Prediction 12%
• Reducing Inflammation 12%
• Evidence-based Support 12%
• Cardiovascular Risk Factors 12%
• Personalized Management 12%
• Inflammatory Risk 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Urokinase Receptor 100%
• Cardiovascular Disease 100%
• Atherosclerosis 25%
• Cardiovascular Risk 25%
• Clinical Trial 12%
• Biological Marker 12%
• Glycoprotein 12%
• Inflammation 12%
• Chronic Inflammation 12%
• Vasculitis 12%
• Diseases 12%
• Pathogenesis 12%